1 active trials 1 recruiting 2 disease areas 2 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04886531 | Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive… | Breast Cancer | Recruiting | 2026-09-03 |
Breast Cancer (1) · HER2-Positive Breast Cancer (1)